Pharmaceutical firm Sun Pharma on Wednesday said it has commercially launched Pantoprazole tablets in the United States, used for treating oesophagus ailments.
41979
Sun Pharma launches Pantoprazole tablets
83928
FDA approves Egrifta for treatment of lipodystrophy in people with HIV
147514
Scientists establish new class of anti-diabetic compound
133627
Momentive Specialty Chemicals to sell business
74685
Teijin Pharma to launch Feburic
94638
Microsulis Medical announces first US patient treated with Accu2i percutaneous microwave tissue ablation system
45298
Pfizer pulling leukemia drug called Mylotarg from US market
13227
Anti-drug resource kit launched
134512
New type 2 diabetes pill, Tradjenta, approved
49072
Viagra can be a wonder drug against heart failure:
69958
Alimera Sciences resubmits new drug application
5285
Azovstal increased production in Q1 2010
128603
Targanta submits Marketing Authorization Application for oritavancin
96310
Hybrigenics starts phase II clinical trial of inecalcitol in chronic lymphocytic leukemia
54889
Generics account for 80 per cent of US prescriptions
94881
Uluru receives marketing approval for Altrazeal in New Zealand
9428
Wockhardt launches nicardipine injections in US